HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Shift from hospital to home would require ‘quantum change’ for care of hematologic malignancies
-
- Is telemedicine a viable option for the treatment of patients with hematologic malignancies?
- Fruquintinib shows promise for advanced non-small cell lung cancer
- Online oncology: Building (dis)connections John Sweetenham, MD, FRCP, FACP
- Many patients with malignant gliomas face barriers to timely hospice enrollment
- Smartphone app, algorithm offer insights into symptom burden among chemotherapy-treated patients
- American Association for Cancer Research presents special recognition awards
- Axicabtagene ciloleucel CAR T-cell therapy shows long-term benefit for non-Hodgkin lymphoma
- Breast milk consumption during bone marrow transplant benefits infants, young children
-
- Collaboration essential for management of immunotherapy toxicities
- Researchers compare late effects of donor graft sources
- Cord blood transplant via NiCord reduces time to neutrophil, platelet recovery
- Data emerge on new immunotherapeutic targets for melanoma
- Data on apalutamide, enzalutamide offer new insights into treatment of nonmetastatic castration-resistant prostate cancer
- Double mastectomy may reduce risk for cancer, death among BRCA1 carriers
- Early HSCT prolongs PFS, not OS, for multiple myeloma
- Extracorporeal photopheresis shows promise for bronchiolitis obliterans syndrome
-
- Gynecologic cancer research disproportionately underfunded
- Herpes zoster vaccine safe, effective after HSCT
- Modified Hopkins conditioning may improve donor engraftment for sickle cell disease
- NCI director: Basic science, big data among key areas of opportunity
- Polygenic risk scores may predict risk for second breast cancer
- Researchers identify factors associated with lower breast cancer recurrence risk
- Treatment of recurrent or metastatic head and neck cancer remains challenging
- Type of conditioning may increase infection risk for lymphoma subtype
-
- BLU-667 shows antitumor activity in RET-altered cancers
- Chemotherapy may limit ability to develop effective CAR T cells
- Lorlatinib exhibits antitumor activity in ALK-positive non-small cell lung cancer
- Survey: Minorities underrepresented in clinical trials, but want to participate
- Study reveals association between industry payments and physicians’ treatment choices
- Rate of subsequent biopsy ‘relatively low’ among women with early breast cancer
- Eating nuts may improve colon cancer survival
- Axitinib plus pembrolizumab promising for late-stage kidney cancer
-
- Many men with penile cancer do not receive guideline-recommended care
- Hyperthermic intraperitoneal chemotherapy prolongs ovarian cancer survival
- Medical students lack knowledge of HPV-positive cancers
- Neoadjuvant dabrafenib, trametinib may improve BRAF-mutant melanoma outcomes
- Delayed sentinel lymph node biopsy safe after melanoma diagnosis
- Risk for death double for pregnant women with anemia
- Stem cell transplant maintains benefit for multiple myeloma in era of novel agents
- Selinexor plus dexamethasone shows activity for multiple myeloma
-
- Challenges receiving, affording health care persist among cancer survivors
- High estrogen receptor heterogeneity doubles breast cancer mortality risk
- HPV vaccination rates increase substantially among males in US
- Copanlisib confers rapid, durable responses for advanced lymphoma
- Experts express concerns about FDA precertification program for health apps
- Clinical practice guidelines released for anticoagulant use in surgery
- Gallbladder cancer death rates on the rise in high-income countries
- FDA grants breakthrough therapy designation to enfortumab vedotin for urothelial cancer
-
- FDA grants priority review to Opdivo-Yervoy combination for colorectal cancer subtype
- FDA expands approval of Blincyto for leukemia at risk for relapse
- FDA expands approval of Adcetris for advanced classical Hodgkin Lymphoma
- FDA expands approval of Tasigna for children with leukemia subtype
- FDA grants priority review to moxetumomab pasudotox for hairy cell leukemia
- Underreporting of adverse event duration impairs physician, patient decision-making
- Drugs approved without supporting trials need more safety-related label changes
- Novel ultrasound device may better detect cancers among women with dense breast tissue
-
- Colonoscopy may be associated with appendicitis
- Molecular signatures of acute myeloid leukemia vary considerably between younger, older patients
- Encorafenib-binimetinib combination improves OS for advanced BRAF-mutated melanoma
- USC Norris Comprehensive Cancer Center names interim director
- Cyramza improves OS, PFS for hepatocellular carcinoma
- Northwestern University Feinberg School of Medicine appoints hematology/oncology division chief
- UT Southwestern appoints chair of surgery department
- Columbia University professor joins Samuel Waxman Cancer Research Foundation advisory board
-
- American Association for Cancer Research names academy fellows